Asia-Pacific Precision Medicine Market by Technology and by Application

Precision Medicine can be defined as the tailoring of medical treatment to individual characteristics of every patient. This novel approach helps doctors in better assessing risk of a disease and suggest the optimal therapy.The Asia Pacific market is projected to reach USD 16.06 billion by 2021, at a CAGR of 12.5% from 2016 to 2021.

Asia Pacific Precision Medicine: Drivers & Restraints
Precision Medicine market in this region is driven by factors like rising demand for personalized treatment, technological innovations and achievements which includes next gene sequencing, bio market based tests and kits, precision imaging and support of government and regulations. However, the market is chiefly constrained by factors like drugs which are specific to patients which may require a more intensive trial.

Get accurate market forecast and analysis on the Asia Pacific Precision Medicine. Request a sample to stay up-to-date on the main trends affecting this market: http://www.marketdataforecast.com/market-reports/asia-pacific-precision-medicine-market-1478/request-sample

Asia Pacific Precision Medicine: Segmentation

By Technology
• Big Data Analytics
• Bioinformatics
• Gene Sequencing
• Drug Discovery
• Companion Diagnostics
• Others

By Application
• Oncology
• CNS
• Immunology
• Respiratory
• Others

Asia Pacific Precision Medicine: Overview
Factors like rising demand for personalized medicine and growing support of government are affecting the market growth positively. The market is chiefly constrained by drugs which are specific to patients which may require a more intensive trial. This factor may restrict the growth of this market in future.

Asia Pacific Precision Medicine: Region-wise Outlook
The market for Precision Medicine in Asia Pacific region is divided based on geography into India, China, Japan, Korea and others. The Precision Medicine market in the Asia-Pacific region is projected to grow at the highest CAGR, which is primarily because of growing aging population. Initiatives from the government and contributions from academic laboratories helped increase growth. Favourable reimbursement policies are also fuelling the market in this region, by attracting the global market players to expand their businesses.

Key Questions Answered
• What is the current and future Precision Medicine outlook in Asia Pacific market? What trends are affecting the Asia Pacific market?

• What is the competitive landscape and market share of major players in the Blood Testing space in Asia Pacific market?

• What are the key, high growth markets that Blood Testing manufacturers should expand into? Which market segments are growing the fastest?

• What are the unmet needs with the Blood Testing currently on the market? How will emerging technologies fulfil these unmet needs?

• What is physician perception and market outlook of Blood Testing?

• What are the challenges and barriers that have hindered widespread adoption of Blood Testing?

Asia Pacific Precision Medicine: Key Players
Pfizer, Roche, Covance, Novartis, Qiagen, Biocrates Life Sciences, Teva Pharmaceutical, Nanostring Technologies, Laboratory Corporation of America Holdings, Tepnel Pharma Services, Intomics, Ferrer InCode, Silicon Biosystems, Eagle Genomics, Medtronic, and Quest Diagnostics, are the major players of Asia Pacific Precision Medicine market.

Reasons to buy Asia Pacific Precision Medicine Report:
• Regional and country-level analysis and forecasts of the study market; providing Insights on the geographical areas in which this industry is prospering

• Segment-level analysis on basis of Technology, application along with market size forecasts and y-o-y estimations to detect key areas of industry growth in detail

• Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics

• Study of macro and micro environmental factors that affect the market presented in an extensive strategic analyses section containing PESTLE and Porter’s Five Forces Analyses

• A comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and Analyst overview to study and sustain the market environment

• Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies

• Expertly devised Market Outlook along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more information, kindly visit, www.marketdataforecast.com.

Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com

This release was published on openPR.